Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia

A. Tosti, B. M. Piraccini, M. Soli

Research output: Contribution to journalArticle

29 Scopus citations

Abstract

Background. Our practical experience indicates that sexual side-effects in subjects taking finasteride 1 mg (Propecia®) for androgenetic alopecia are much less common than reported in the literature. Objective. To evaluate the sexual function in subjects taking finasteride (1 mg) compared with age-matched controls using the International Index of Erectile Function (IIEF). Methods. The IIEF, a brief, reliable questionnaire, was self-administered to 236 patients taking Propecia® and 236 age-matched males attending the Department of Dermatology of the University of Bologna. Results. Statistical analysis showed no differences between scores obtained with the IIEF in subjects taking finasteride and controls. Conclusions. The sexual and erectile function of subjects taking finasteride does not significantly differ from that of age-matched controls. This is consistent with the experience of many dermatologists who do not see sexual or erectile dysfunction in patients taking Propecia®.

Original languageEnglish (US)
Pages (from-to)418-421
Number of pages4
JournalJournal of the European Academy of Dermatology and Venereology
Volume15
Issue number5
DOIs
StatePublished - Nov 20 2001
Externally publishedYes

Keywords

  • Hair loss
  • International Index of Erectile Function (IIEF)
  • Male pattern baldness
  • Treatment

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia'. Together they form a unique fingerprint.

  • Cite this